Vista RX MD is a specialized pharmaceutical procurement and distribution platform, dedicated to the delivery of compounded GLP-1 receptor agonists and therapeutic peptides. We provide licensed U.S. medical professionals with reliable access to premium formulations produced under stringent quality and regulatory standards.

Procurement & Fulfillment Model

Vista RX MD operates as a strategic purchasing organization tailored to clinical practices and licensed healthcare providers. Our model consolidates:

  • Multi-source fulfillment from FDA-registered 503B outsourcing facilities and 503A compounding pharmacies
  • Contract pricing optimization to support volume-based and protocol-driven treatment programs
  • Inventory assurance to mitigate supply disruptions and ensure continuity of care

Manufacturing Standards & Compliance

All compounding partners within our network adhere to:

  • cGMP (Current Good Manufacturing Practice) guidelines as defined under 21 CFR Parts 210/211
  • MHRA, ISO, or equivalent international certifications for sterile manufacturing
  • Full documentation including:
    • Certificates of Analysis (COAs)
    • Lot-specific sterility and potency reports
    • Chain-of-custody and traceability documentation

Therapeutic Portfolio

Formulation Categories:

  • GLP-1 Receptor Agonists: Including Semaglutide, Tirzepatide, and Retatrutide analogs
  • Custom peptide therapies: Targeting metabolic, hormonal, and regenerative pathways

Form Format:

  • All products are provided in lyophilized (dry powder) form to ensure sterility and stability, suitable for reconstitution per clinical protocols.

Customization Options:

  • Single-agent or multi-pathway blends (e.g., GLP-1/GIP/Glucagon receptor agonists)
  • Concentration adjustments based on specific dosing protocols
  • Compounding for alternative delivery routes (where applicable)

Quality Assurance & API Integrity

  • APIs are sourced exclusively from FDA-inspected or EU/ICH Q7-compliant manufacturers
  • Every lot is supported by a Certificate of Analysis (COA) verifying identity, potency, purity, and microbial integrity
  • Compounding is executed in validated cleanroom environments under USP <797> and <800> compliance (where applicable)

Clinical Use Cases Supported

  • Medical weight loss programs
  • Endocrine/metabolic dysfunction protocols
  • Peptide-based longevity and performance medicine

Mission Statement

Vista RX MD exists to enable evidence-driven providers to deploy advanced peptide therapies through a secure, compliant, and cost-efficient supply chain—expanding access to high-quality compounded medications and supporting optimal patient outcomes.